close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about TSVT

Recent news which mentions TSVT

< Previous 1 2 3 Next >
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023
Tickers ARBB ASML ASX BFST
Tags TTD SHYF Analyst Ratings
From Benzinga
Where 2seventy bio Stands With Analysts
Tickers TSVT
Tags TSVT BZI/AAR Analyst Ratings
From Benzinga
Arcellx's Lead Product Candidate Hit By FDA Clinical Hold For Multiple Myeloma, Stock Falls
Tickers ACLX GILD TSVT
Tags GILD ACLX Biotech
From Benzinga
Cancer Drug Trials Put On Hold After Patients Died
Tickers MRSN TSVT
Tags Ovarian Cancer MRSN TSVT
From Benzinga
2seventy Bio Pauses Pediatric Blood Cancer Trial After Patient Death, Stock Plunges
Tickers TSVT
Tags Small Cap Market News Health Care
From Benzinga
Benzinga Pro's Top 5 Stocks To Watch For Friday, May 12, 2023: CMCSA, KR, ON, TSVT, CMND
Tickers CMCSA CMND KR ON
Tags Market News CMND Pre/Market Outlook
From Benzinga
2seventy bio: Q1 Earnings Insights
Tickers TSVT
Tags BZI/Recaps Earnings TSVT
From Benzinga
Stocks That Hit 52-Week Lows On Monday
Tickers NVEE NVX OCGN OGI
Tags VCIG POAI QRTEA
From Benzinga
Stocks That Hit 52-Week Lows On Friday
Tickers MSGE MYFW MYNZ MYTE
Tags TPHS SVRE PFC
From Benzinga
2seventy bio's Return On Capital Employed Overview
Tickers TSVT
Tags Earnings BZI/ROCE TSVT
From Benzinga
Wedbush Maintains Outperform Rating for 2seventy bio: Here's What You Need To Know
Tickers TSVT
Tags TSVT Analyst Ratings BZI/AAR/UPDATE
From Benzinga
Where 2seventy bio Stands With Analysts
Tickers TSVT
Tags Analyst Ratings Benzinga Market News
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Tickers BLPH CBIO CPHI CUTR
Tags CPHI CUTR BLPH
From Benzinga
Bristol Myers-2seventy Partnered Abecma Cuts Risk Of Disease Progression, Death By 51% In Pretreated Myeloma Patients
Tickers BMY TSVT
Tags News General Small Cap
From Benzinga
SVB Leerink Maintains Outperform Rating for 2seventy bio: Here's What You Need To Know
Tickers TSVT
Tags TSVT Benzinga Market News
From Benzinga
Expert Ratings for 2seventy bio
Tickers TSVT
Tags Market News Benzinga Analyst Ratings
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
Tickers PBLA PCSA PEAR PEV
Tags TCRR SBEV WLDS
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Tickers OCGN OCX OGI OLO
Tags VMEO SFIX SIFY
From Benzinga
4 Analysts Have This to Say About 2seventy bio
Tickers TSVT
Tags Market News Benzinga Analyst Ratings
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
Tickers ABCB ACLX AMD AMGN
Tags PBR OTLK TXRH
From Benzinga
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
Tickers BBIO BMY LEXX LIAN
Tags Health Care RSLS Market News
From Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
Tickers ADMP AEMD ALPN ARDS
Tags ASND Penny Stocks AEMD
From Benzinga
2seventy Bio Shares Jump On Positive Data From Bristol Myers-Partnered Cancer Immunotherapy
Tickers BMY TSVT
Tags News General BMY
From Benzinga
2 Biotech Stocks That Could Soar in the Third Quarter
Tickers BLUE BMY TEVA TSVT
Tags Market News BMY TEVA
From Motley Fool
Did Bluebird Bio Stock Just Get a New Lease on Life?
Tickers BLUE TSVT
Tags BLUE TSVT Market News
From Motley Fool
The Top E-Commerce Company to Buy for Summer 2022
Tickers AMZN BJ GRPN HTZ
Tags BJ Market Insight, Financial Articles HTZ
From InvestorPlace
The 5 Top Profit & Protection Stocks to Buy for 2022
Tickers AMZN BBBY BJ BLUE
Tags WMT Market News TGT
From InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
Tickers TDS TDUP TDY TECH
Tags Benzinga XHR 52/Week Lows
From Benzinga
ASCO 2022: Surprising News in Cancer Research
Tickers ACLX ADPT BMY GILD
Tags RHHBY Recent Press Releases LGND
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022
Tickers ACCD AJG ANVS ARTA
Tags TSVT TAL GMAB
From Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today